https://www.selleckchem.com/pr....oducts/Erlotinib-Hyd
01). At 8 years of follow-up, SVD occurred in 30.2% of patients (clinically relevant 9.3%). Transesophageal echocardiography revealed thickened and reduced-mobility leaflets in 80% and 73% of SVD cases, respectively. No baseline or procedural factors were associated with SVD. THV underexpansion (3.5%) or eccentricity (8.2%) had no impact on valve hemodynamics/SVD at follow-up. CONCLUSIONS A gradual THV hemodynamic deterioration occurred throughout a 10-year period, leading to SVD in ∼30% of patients (clinically relevant
إعجاب
علق
شارك
